Results 11 to 20 of about 17,714 (234)
Antiemetic research: future directions [PDF]
Supportive Care in Cancer, 2010 As a part of reviewing the Multinational Association of Supportive Care in Cancer (MASCC) antiemetic guidelines in Perugia in 2009, an expert group identified directions for future antiemetic research.In future trials, the prediction of nausea and vomiting may combine algorithms based on observed prognostic factors relating to the patient and the ...
Olver, Ian +5 more
openaire +6 more sources
Management of chemotherapy induced emesis [PDF]
Archive of Oncology, 2004 Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently.
Roila Fausto
doaj +3 more sources
BMC Cancer, 2021 Background Among patients with colorectal cancer (CRC) treated with oxaliplatin (L-OHP)-based chemotherapy, delayed chemotherapy-induced nausea and vomiting (CINV) have not been well controlled.
Mototsugu Shimokawa +8 more
doaj +1 more source
Frontiers in Oncology, 2021 IntroductionThe aim of this study is to rigorously review the efficacy and safety of olanzapine in chemotherapy-induced nausea and vomiting (CINV) settings including (1) at 5- and 10-mg doses, and (2) the setting of highly emetogenic chemotherapy (HEC ...
Dong-Yang Wang +3 more
doaj +1 more source
Prophylaxis of postoperative nausea and vomiting with combination of ondansetron and dexametasone in urology: Prophylaxis of postoperative nausea and vomiting [PDF]
Serbian Journal of Anesthesia and Intensive Therapy, 2016 Introduction: Postoperative nausea and vomiting is an unpleasant, distressing and exhausting experience for patients. There are inconsistent findings concerning approach to the management of PONV and disagreement as to whether prophylaxis of PONV should ...
Gvozdić Branka +2 more
doaj +1 more source
Brazilian Journal of Oncology, 2022 Objectives: This study aimed to characterize the clinical profile and the factors that predispose chemotherapy-induced nausea and vomiting (CINV) in the acute and delayed phases. Methods: A retrospective cohort study
Ariádne Sousa Albuquerque +5 more
doaj +1 more source
Rotatory nystagmus after granisetron administration
Saudi Journal of Emergency Medicine, 2021 Background: Granisetron is a popular antiemetic medication used in the emergency department to control nausea and vomiting with an excellent side effect profile among adults and pediatric, in both healthy and oncology patients.
Abdulelah Shafiq Abualfraj +3 more
doaj +1 more source
Frontiers in Oncology, 2020 Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and feared side effects in cancer patients undergoing chemotherapy. Scientific evidence proves its detrimental impact on a patient's quality of life (QoL), treatment compliance ...
Ashok K. Vaid +10 more
doaj +1 more source
Colombian Journal of Anesthesiology, 2023 The aim of this special article is to summarize and discuss, from an anesthesia perspective, the network meta-analysis on drugs used for the prevention of postoperative nausea and vomiting after general anesthesia, in agreement with the Cochrane Colombia
Mario Zamudio Burbano +2 more
doaj +1 more source